Nathan M. Radcliffe, MD

In this video, Nathan M. Radcliffe, MD, associate clinical professor of ophthalmology at Mount Sinai School of Medicine, discusses:

therapeutic treatment advances in glaucoma, including biodegradable sustained-release implants;
how neuroprotective agents represent “final hope” in glaucoma treatment;
glaucoma as a "guilt-free disease” and how to navigate patient concerns on supplements;
why an annual exam is vital for at-risk patients with family history of glaucoma;
the current role of artificial intelligence, machine learning and screening; and
how improvements in treatment provide greater quality of life for patients.

Glaucoma Awareness